Statements (34)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
histamine H2 receptor antagonist |
| gptkbp:approvedBy |
1988
|
| gptkbp:ATCCode |
A02BA04
|
| gptkbp:brand |
Axid
|
| gptkbp:CASNumber |
76963-41-2
|
| gptkbp:chemicalClass |
thiazole
|
| gptkbp:discoveredBy |
gptkb:Eli_Lilly_and_Company
|
| gptkbp:eliminationHalfLife |
1-2 hours
|
| gptkbp:excretion |
renal
|
| gptkbp:hasMolecularFormula |
C12H21N5O2S2
|
| https://www.w3.org/2000/01/rdf-schema#label |
nizatidine
|
| gptkbp:KEGGID |
D08213
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
blocks H2 receptors in stomach
|
| gptkbp:meltingPoint |
160-162°C
|
| gptkbp:metabolism |
minimal hepatic
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL1431
4884 4715 DB00586 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
diarrhea
dizziness fatigue headache |
| gptkbp:UNII |
6X5848Q8FU
|
| gptkbp:usedFor |
treatment of peptic ulcer disease
treatment of Zollinger-Ellison syndrome treatment of gastroesophageal reflux disease |
| gptkbp:bfsParent |
gptkb:famotidine
gptkb:H2_blocker |
| gptkbp:bfsLayer |
6
|